An international survey of healthcare providers' knowledge of cardiac complications of cancer treatments

Cardio-Oncology
J PengSusan F Dent

Abstract

Cardio-oncology is a young sub-specialty that addresses the needs of cancer patients at risk of, or who have experienced cancer therapy related cardiac dysfunction (CTRCD). This study assessed clinicians' understanding of cardio-oncology, opinions towards current practice, and approach to diagnosing and managing CTRCD. A 45-question survey was administered online via Survey Monkey and WeChat to health care providers (HCPs) comprising of cardiologists, oncologists, and others from September 2017 to March 2018. Implementation of the survey followed a modified Dillman's Total Design Method. In total, 160 responses were collected from 22 countries; majority were from cardiologists (53.8%) and oncologists (32.5%). The remaining 13.7% identified themselves as "others," including general internists, cardio-oncologists, pediatric oncologists, radiation oncologists, cardiac rehabilitation therapists, nurse practitioners, research students, and pharmacists. In the setting of metastatic cancer, there was a difference in risk tolerance for cardiotoxicity between subspecialties. In this case, more cardiologists (36.7%) accepted a 5-10% risk of cardiotoxicity compared to oncologists (20.0%). Majority of cardiologists felt that cardiotoxicity...Continue Reading

References

Nov 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael S EwerDaniel J Lenihan
Mar 11, 2010·Current Pharmaceutical Design·A UrruticoecheaG Capellá
Jun 12, 2010·Journal of Oncology Practice·Laura LevitBetty Ferrell
Nov 20, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G CuriglianoUNKNOWN ESMO Guidelines Working Group
Feb 19, 2013·Future Oncology·Carmen Criscitiello, Giuseppe Curigliano
Mar 29, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Janet S de MoorJulia H Rowland
Apr 16, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Claire KellyMark Saunders
Jun 27, 2015·Journal of the American College of Cardiology·Ana BaracPamela S Douglas
Feb 27, 2016·CA: a Cancer Journal for Clinicians·Giuseppe CuriglianoCarlo Maria Cipolla
Mar 16, 2016·Circulation·Ryan J KoeneSuma H Konety
Apr 27, 2016·Current Oncology Reports·Michael E LayounEric H Yang
Nov 29, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edith PituskinD Ian Paterson
Dec 6, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Saro H ArmenianDaniel Lenihan
Apr 4, 2017·International Journal of Cardiology·Ludovic JovenauxFranck Thuny
Mar 16, 2018·Journal of the American College of Cardiology·Mônica Samuel AvilaEdimar Alcides Bocchi
Mar 20, 2018·Critical Reviews in Oncology/hematology·Ilaria DepetrisFrancesco Leone
Jul 7, 2018·Therapeutic Advances in Medical Oncology·Jaskanwal D SaraAxel Grothey

❮ Previous
Next ❯

Citations

Apr 10, 2021·Clinical Oncology : a Journal of the Royal College of Radiologists·M S AndresA R Lyon
Feb 20, 2021·Current Opinion in Supportive and Palliative Care·Jiliu PanAlexander R Lyon
Aug 6, 2021·JNCI Cancer Spectrum·Arielle S GillmanRebecca A Ferrer

❮ Previous
Next ❯

Software Mentioned

Survey Monkey
SurveyMonkey

Related Concepts

Related Feeds

Cardiotoxicity

Cardiotoxicity refers to the muscle damage or dysfunction of heart electrophysiology caused by drug intake or due to disease complications. It is a well-known side effect of several cytotoxic drugs, especially of the anthracyclines and can lead to long term morbidity. Here is the latest research.